News

Posts are organized into categories for ease of navigation:

  • Database release

    Revised entries:

    • (FDA) KRAS p.G12C and sensitivity to sotorasib’s description was revised to remove underscores.
    • (Preclinical) KRAS somatic variants and sensitivity to FGFR1 inhibitor + trametinib was revised to remove a trailing space from the therapy name.
    Continue reading
  • Database release

    Revised entries:

    • (FDA) KRAS p.G12C and sensitivity to sotorasib’s description was revised to remove underscores.
    • (Preclinical) KRAS somatic variants and sensitivity to FGFR1 inhibitor + trametinib was revised to remove a trailing space from the therapy name.
    Continue reading
  • Algorithm release 0.4.2

    This release utilizes the v.2021-02-04 release of the underlying MOAlmanac database.

    Continue reading
  • Database release

    Added entries:

    • (FDA) BCR-ABL1 and sensitivity to asciminib in chronic phase chronic myeloid leukemia.
    • (Clinical evidence) SPOP missense somatic variants and favorable prognosis in de-novo metastatic castration-sensitive prostate cancer.
    • (Clinical evidence) SPOP missense somatic variants and sensitivity to abiraterone in metastatic castration-resistant prostate cancer
    • (Clinical evidence) SPOP missense somatic variants and sensitivity to anti-androgen therapy.
    • (Inferential) CD274 amplification and sensitivity to atezolizumab in non-small cell lung cancer.
    Continue reading
  • Database release

    Added entries:

    • (FDA) EGFR exon 20 insertion variants and sensitivity to mobocertinib in non-small cell lung cancer.
    Continue reading